Results 31 to 40 of about 4,275,154 (300)

Differences in level of confidence in diabetes care between different groups of trainees: the TOPDOC diabetes study [PDF]

open access: yes, 2014
Background There is an increasing prevalence of diabetes. Doctors in training, irrespective of specialty, will have patients with diabetes under their care.
George, Jyothis T   +10 more
core   +1 more source

Dietary Protein Intake and Peritoneal Protein Losses in Peritoneal Dialysis Patients

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Peritoneal dialysis (PD) patients lose protein in their waste dialysate, potentially increasing their risk for malnutrition. We wished to determine whether there was any association between losses and dietary protein intake (DPI). Methods DPI was assessed from 24‐h dietary recall using Nutrics software.
Haalah Shaaker, Andrew Davenport
wiley   +1 more source

On the accasion of the birthday of Mikhail Efimovich Zelzer

open access: yesСахарный диабет, 2010
Михаилу Ефимовичу Зельцеру, заслуженному деятелю науки Казахстана, академику Академии профилактической медицины Казахстана 23 сентября 2010 года исполнилось 80 лет.
Editorial team Diabetes Mellitus
doaj   +1 more source

Dietary dairy product intake and incident type 2 diabetes: a prospective study using dietary data from a 7-day food diary [PDF]

open access: yes, 2014
The consumption of specific dairy types may be beneficial for the prevention of diabetes. Abstract: The aim of this study was to investigate the association between total and types of dairy product intake and risk of developing incident type 2 diabetes,
Kay-Tee Khaw   +5 more
core   +1 more source

Ethnic differences in adiposity and diabetes risk – insights from genetic studies [PDF]

open access: yes, 2020
Type 2 diabetes is more common in non-Europeans and starts at a younger age and at lower BMI cut-offs. This review discusses the insights from genetic studies about pathophysiological mechanisms which determine risk of disease with a focus on the role of
Bell, J.D.   +7 more
core   +2 more sources

Effects of the Fluid Replacement Method During Online Hemodiafiltration on the Solute Removal Performance and Biocompatibility Using the Asymmetric Cellulose Triacetate Membrane

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Pre‐dilution online hemodiafiltration (Pre‐HDF) is predominantly used in Japan, whereas post‐dilution online HDF (Post‐HDF) is more common in Europe. An asymmetric cellulose triacetate (ATA) membrane may improve biocompatibility.
Kenji Sakurai   +4 more
wiley   +1 more source

The new drug saxagliptin is now registrated in Russia

open access: yesСахарный диабет, 2010
23 ноября в Москве состоялся симпозиум, посвященный появлению в России нового препарата Онглиза (саксаглиптин) из группы ингибиторов дипептидилпептидазы-4 (ДПП-4).
Editorial team Diabetes Mellitus
doaj   +1 more source

Diabetes 1.5: Ketone-Prone Diabetes [PDF]

open access: yesClinical Diabetes, 2015
Ketone-prone diabetes (KPD) is considered one of the atypical diabetes syndromes because its presentation can lead to misdiagnosis of the type of diabetes. Patients with KPD present in diabetic ketoacidosis (DKA), but once the DKA resolves, some patients can discontinue insulin and maintain adequate glycemic control with oral agents (1).
Safder, Sabina B., Mortada, Rami
openaire   +2 more sources

Transferrin receptor 1‐mediated iron uptake supports thermogenic activation in human cervical‐derived adipocytes

open access: yesFEBS Letters, EarlyView.
In this study, we found that human cervical‐derived adipocytes maintain intracellular iron level by regulating the expression of iron transport‐related proteins during adrenergic stimulation. Melanotransferrin is predicted to interact with transferrin receptor 1 based on in silico analysis.
Rahaf Alrifai   +9 more
wiley   +1 more source

Russian Association of Endocrinologists about the introduction of Diabeton MR (60 mg tablets)

open access: yesСахарный диабет, 2011
Хорошо известный препарат Диабетон МВ 30 мг успешно применяется в России и мире для лечения больных сахарным диабетом 2 типа (СД2) с 2000 года. Доказанная эффективность и безопасность Диабетона МВ 30 мг послужила основанием для его широкого применения в ...
Editorial team Diabetes Mellitus
doaj   +1 more source

Home - About - Disclaimer - Privacy